scholarly article | Q13442814 |
P356 | DOI | 10.1039/C4OB00164H |
P698 | PubMed publication ID | 24737243 |
P2093 | author name string | Chung Yen Ang | |
Si Yu Tan | |||
Yanli Zhao | |||
P2860 | cites work | Photochemical Instability of CdSe Nanocrystals Coated by Hydrophilic Thiols | Q58479728 |
Quantum dots for live cells, in vivo imaging, and diagnostics | Q24532049 | ||
Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity | Q24608070 | ||
A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors | Q25257257 | ||
Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle | Q28193368 | ||
Formation of high-quality CdTe, CdSe, and CdS nanocrystals using CdO as precursor | Q28207151 | ||
Ultrasound triggered release of cisplatin from liposomes in murine tumors | Q28238830 | ||
Microtubules as a target for anticancer drugs | Q28253993 | ||
Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles | Q28283289 | ||
Cisplatin: mode of cytotoxic action and molecular basis of resistance | Q29615385 | ||
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications | Q29615464 | ||
Nanoparticle therapeutics: an emerging treatment modality for cancer | Q29615628 | ||
Recent advances with liposomes as pharmaceutical carriers | Q29616702 | ||
Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology | Q29617209 | ||
In vivo cancer targeting and imaging with semiconductor quantum dots | Q29617278 | ||
Compact cysteine-coated CdSe(ZnCdS) quantum dots for in vivo applications | Q30484740 | ||
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin | Q30540353 | ||
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia | Q31123048 | ||
Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study | Q33363068 | ||
Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery | Q33413468 | ||
Engineered affinity proteins--generation and applications | Q33442549 | ||
Practical intravital two-photon microscopy for immunological research: faster, brighter, deeper | Q33523268 | ||
Synthesis of novel dendrimers having aspartate grafts and their ability to enhance the aqueous solubility of model drugs | Q33532897 | ||
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin | Q33540751 | ||
HPMA copolymers: origins, early developments, present, and future | Q33719148 | ||
Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. | Q33750086 | ||
A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity | Q33774858 | ||
Ligand binding to integrins | Q33912940 | ||
Gold nanoparticles in chemical and biological sensing | Q33915917 | ||
Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization | Q33939514 | ||
The role of glutathione in brain tumor drug resistance | Q34029649 | ||
Poly(ethylene oxide)-block-polyphosphester-based Paclitaxel Conjugates as a Platform for Ultra-high Paclitaxel-loaded Multifunctional Nanoparticles | Q34069122 | ||
Solubilization and anticancer-activity enhancement of Methotrexate by novel dendrimeric nanodevices synthesized in one-step reaction. | Q34161051 | ||
Gene therapy finds its niche | Q34163207 | ||
Mesoporous silica nanoparticles: A multifunctional nano therapeutic system | Q38050033 | ||
In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles | Q38107467 | ||
Supramolecular self-assemblies as functional nanomaterials. | Q38119852 | ||
Biodegradable long-circulating polymeric nanospheres | Q38569096 | ||
Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery | Q39079389 | ||
Enhanced photodynamic efficiency of an aptamer-guided fullerene photosensitizer toward tumor cells. | Q39116717 | ||
Phthalocyanines functionalized with 2-methyl-5-nitro-1H-imidazolylethoxy and 1,4,7-trioxanonyl moieties and the effect of metronidazole substitution on photocytotoxicity. | Q39122795 | ||
Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram | Q39144084 | ||
Cyclodextrin-derived pH-responsive nanoparticles for delivery of paclitaxel. | Q39165355 | ||
Toward the next-generation nanomedicines: design of multifunctional multiblock polyurethanes for effective cancer treatment | Q39194162 | ||
A liposomal system capable of generating CO2 bubbles to induce transient cavitation, lysosomal rupturing, and cell necrosis | Q39284840 | ||
Regulation of intracellular pH in cancer cell lines under normoxia and hypoxia | Q39285356 | ||
Spacer intercalated disassembly and photodynamic activity of zinc phthalocyanine inside nanochannels of mesoporous silica nanoparticles | Q39300008 | ||
cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer | Q39319742 | ||
Targeted delivery of insoluble cargo (paclitaxel) by PEGylated chitosan nanoparticles grafted with Arg-Gly-Asp (RGD). | Q39353605 | ||
Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles | Q39451814 | ||
RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment | Q39454509 | ||
Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors | Q39462712 | ||
Smart multifunctional hollow microspheres for the quick release of drugs in intracellular lysosomal compartments. | Q39507570 | ||
Advanced materials for co-delivery of drugs and genes in cancer therapy | Q39513734 | ||
Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug. | Q39563868 | ||
Polymer-Caged Nanobins for Synergistic Cisplatin−Doxorubicin Combination Chemotherapy | Q39631781 | ||
Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. | Q39672199 | ||
Photothermal effects of supramolecularly assembled gold nanoparticles for the targeted treatment of cancer cells | Q39714970 | ||
Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin | Q39728421 | ||
A liposome-based nanostructure for aptamer directed delivery | Q39760965 | ||
Mediating tumor targeting efficiency of nanoparticles through design | Q39864411 | ||
Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer | Q40081435 | ||
Anti-oxidant and anti-atherogenic properties of liposomal glutathione: studies in vitro, and in the atherosclerotic apolipoprotein E-deficient mice | Q40115952 | ||
Mechanisms of photosensitization | Q40171268 | ||
Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a 'Trojan horse'. | Q40248347 | ||
Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging | Q40273908 | ||
Multidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione-dependent drug efflux | Q40325456 | ||
Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin | Q40349362 | ||
Evaluation of pegylated liposomal doxorubicin (Doxil) as second-line chemotherapy of squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group | Q40350784 | ||
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. | Q40447478 | ||
Design of Environment‐Sensitive Supramolecular Assemblies for Intracellular Drug Delivery: Polymeric Micelles that are Responsive to Intracellular pH Change | Q40628028 | ||
Synthesis of linear, beta-cyclodextrin-based polymers and their camptothecin conjugates | Q40634339 | ||
Cancer multidrug resistance | Q40827165 | ||
A supramolecular approach for preparation of size-controlled nanoparticles | Q41332964 | ||
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery | Q41847599 | ||
Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice | Q42279946 | ||
Inorganic Nanoparticles for MRI Contrast Agents | Q57258903 | ||
Self-Assembly Strategy for the Preparation of Polymer-Based Nanoparticles for Drug and Gene Delivery | Q57343394 | ||
Supramolecular nanoparticle carriers self-assembled from cyclodextrin- and adamantane-functionalized polyacrylates for tumor-targeted drug delivery | Q57348013 | ||
Synthesis, properties, and applications of magnetic iron oxide nanoparticles | Q57359490 | ||
Mesoporous silicananoparticles for the design of smart delivery nanodevices | Q57364103 | ||
Dual-responsive drug release from oligonucleotide-capped mesoporous silica nanoparticles | Q57364638 | ||
Vesicles from supramolecular amphiphiles | Q57364926 | ||
Size- and Shape-Controlled Magnetic (Cr, Mn, Fe, Co, Ni) Oxide Nanocrystals via a Simple and General Approach | Q58479678 | ||
Shape-controlled synthesis of gold and silver nanoparticles | Q34164603 | ||
Photodynamic therapy for cancer | Q34194073 | ||
Physical mechanisms of generation and deactivation of singlet oxygen | Q34196567 | ||
Nanoparticle delivery of cancer drugs. | Q34213157 | ||
Gene therapy for human genetic disease? | Q34227501 | ||
The changing faces of glutathione, a cellular protagonist | Q34269360 | ||
The present and future role of photodynamic therapy in cancer treatment | Q34337882 | ||
Structure and design of polymeric surfactant-based drug delivery systems | Q34343009 | ||
Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis | Q34367669 | ||
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine | Q34419681 | ||
Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging | Q34433878 | ||
PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality | Q34493501 | ||
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer | Q34546077 | ||
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo | Q34550075 | ||
Photodynamic therapy: a clinical reality in the treatment of cancer | Q34571806 | ||
Cationic poly-L-lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo | Q34635753 | ||
Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille Calmette-Guérin immunotherapy | Q34707874 | ||
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications | Q34785770 | ||
Folate-mediated delivery of macromolecular anticancer therapeutic agents | Q34804841 | ||
Quantum dots versus organic dyes as fluorescent labels | Q34816662 | ||
Cancer. The metastasis cascade | Q34837736 | ||
Biodegradable and amphiphilic block copolymer-doxorubicin conjugate as polymeric nanoscale drug delivery vehicle for breast cancer therapy | Q34878879 | ||
MRI of the tumor microenvironment. | Q34918656 | ||
Global and regional causes of death | Q35004752 | ||
Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves | Q35049783 | ||
Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine | Q35387777 | ||
Photosensitizer-antibody conjugates for detection and therapy of cancer | Q35620850 | ||
Controlled release systems for DNA delivery | Q35826516 | ||
Dendrimers and dendritic polymers in drug delivery | Q36022312 | ||
Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities. | Q36167027 | ||
Quantum dots as cellular probes | Q36186969 | ||
Chemotherapeutic evaluation of a synthetic tubulysin analogue-dendrimer conjugate in c26 tumor bearing mice | Q36315671 | ||
Fluorescence probes used for detection of reactive oxygen species | Q36317620 | ||
Dendrimers in gene delivery | Q36323319 | ||
Advances in fluorescence imaging with quantum dot bio-probes. | Q36327305 | ||
Dendrimers: novel polymeric nanoarchitectures for solubility enhancement. | Q36418007 | ||
Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection | Q36448777 | ||
Silica-based mesoporous organic-inorganic hybrid materials | Q36469015 | ||
Polymer conjugates as anticancer nanomedicines | Q36561667 | ||
A review of stimuli-responsive nanocarriers for drug and gene delivery | Q37080358 | ||
The functions and applications of RGD in tumor therapy and tissue engineering | Q37091818 | ||
On-demand drug release system for in vivo cancer treatment through self-assembled magnetic nanoparticles | Q37114971 | ||
Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery. | Q37138766 | ||
Integrins in angiogenesis and lymphangiogenesis | Q37170752 | ||
Gold nanoparticles in delivery applications | Q37191739 | ||
Magnetic nanoparticles in MR imaging and drug delivery. | Q37192908 | ||
Biological applications of gold nanoparticles | Q37258280 | ||
Impact of nanotechnology on drug delivery. | Q37389440 | ||
Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications | Q37498841 | ||
Dendrimers as carriers for delivery of chemotherapeutic agents | Q37522421 | ||
Lipid-coated Cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy | Q37531501 | ||
Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin | Q37580087 | ||
Microtubules and resistance to tubulin-binding agents | Q37690565 | ||
Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives | Q37774596 | ||
pH control mechanisms of tumor survival and growth | Q37790658 | ||
Enzyme-triggered nanomedicine: drug release strategies in cancer therapy. | Q37799614 | ||
Unlocked nucleic acid--an RNA modification with broad potential. | Q37856768 | ||
New methods of drug delivery | Q37970107 | ||
Nucleic acid and peptide aptamers: fundamentals and bioanalytical aspects. | Q37972851 | ||
Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation. | Q37976436 | ||
Doxil®--the first FDA-approved nano-drug: lessons learned | Q38000876 | ||
The effect of nanoparticle size, shape, and surface chemistry on biological systems | Q38004588 | ||
Mechanistic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur-donor biomolecules | Q38034439 | ||
Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects | Q42575787 | ||
Disterolphospholipids: nonexchangeable lipids and their application to liposomal drug delivery | Q42619600 | ||
Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots | Q42807706 | ||
pH-operated nanopistons on the surfaces of mesoporous silica nanoparticles. | Q42924183 | ||
Preparation of surface imprinting polymer capped Mn-doped ZnS quantum dots and their application for chemiluminescence detection of 4-nitrophenol in tap water | Q42940740 | ||
Snap-top nanocarriers | Q42978953 | ||
Mechanisms of singlet-oxygen and superoxide-ion generation by porphyrins and bacteriochlorins and their implications in photodynamic therapy | Q43008074 | ||
Dual-controllable stepwise supramolecular interconversions. | Q43070691 | ||
Azobenzene-based light-responsive hydrogel system | Q43202336 | ||
Four-year analysis of platinum and anthracycline combination for ovarian cancer | Q43456329 | ||
Photochemical properties and shape evolution of CdSe QDs in a non-injection reaction | Q43532669 | ||
Aptamer-targeted hyperbranched polymers: towards greater specificity for tumours in vivo. | Q43639193 | ||
Design of folic acid-conjugated nanoparticles for drug targeting | Q43758625 | ||
Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. | Q44286594 | ||
Photodynamic therapy of bladder cancer. A new option | Q44727503 | ||
Engineering a hollow nanocontainer platform with multifunctional molecular machines for tumor-targeted therapy in vitro and in vivo. | Q44827332 | ||
Binding ability and assembly behavior of beta-cyclodextrin complexes with 2,2'-dipyridine and 4,4'-dipyridine | Q44887521 | ||
New amphiphilic silicon(IV) phthalocyanines as efficient photosensitizers for photodynamic therapy: synthesis, photophysical properties, and in vitro photodynamic activities. | Q45062732 | ||
Convergent dendrons and dendrimers: from synthesis to applications | Q45142211 | ||
PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin | Q45253881 | ||
Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. | Q45953091 | ||
Probing the Cytotoxicity Of Semiconductor Quantum Dots | Q46112957 | ||
Selective synthesis of CdTe and high luminescence CdTe/CdS quantum dots: the effect of ligands | Q46122750 | ||
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery | Q46181738 | ||
Recent advances from the National Cancer Institute Alliance for Nanotechnology in Cancer | Q46187087 | ||
Inclusion behavior of beta-cyclodextrin with bipyridine molecules: factors governing host-guest inclusion geometries | Q46196333 | ||
Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin. | Q46523182 | ||
Biodegradation of iron oxide nanocubes: high-resolution in situ monitoring | Q46604977 | ||
Effect of the thiol-thiolate equilibrium on the photophysical properties of aqueous CdSe/ZnS nanocrystal quantum dots | Q46608000 | ||
Modified ligand-exchange for efficient solubilization of CdSe/ZnS quantum dots in water: a procedure guided by computational studies | Q46644875 | ||
Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy | Q46741857 | ||
Studies on the mechanism of the hematoporphyrin-sensitized photooxidation of 1,3-diphenylisobenzofuran in ethanol and unilamellar liposomes | Q46869612 | ||
Stimulated release of size-selected cargos in succession from mesoporous silica nanoparticles. | Q47315709 | ||
Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles | Q50669171 | ||
A versatile strategy for quantum dot ligand exchange | Q51083523 | ||
Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery | Q51153020 | ||
Biocompatible pillararene-assembly-based carriers for dual bioimaging. | Q51175718 | ||
Graphene oxide wrapping on squaraine-loaded mesoporous silica nanoparticles for bioimaging. | Q51343672 | ||
Functional mesoporous silica nanoparticles for photothermal-controlled drug delivery in vivo. | Q51345728 | ||
Nucleic acid functionalized graphene for biosensing. | Q51458636 | ||
Aptamers as therapeutics. | Q51813594 | ||
PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery. | Q52579080 | ||
Anticancer drug development: the grand challenges. | Q55052796 | ||
Applications of magnetic nanoparticles in biomedicine | Q56031415 | ||
Physical and chemical properties of singlet molecular oxygen | Q56058401 | ||
Electron–electron and electron‐hole interactions in small semiconductor crystallites: The size dependence of the lowest excited electronic state | Q56289331 | ||
The Quantum Mechanics of Larger Semiconductor Clusters ("Quantum Dots") | Q56442863 | ||
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer | Q56626150 | ||
The Effect of Organic Ligand Binding on the Growth of CdSe Nanoparticles Probed by Ab Initio Calculations | Q56921223 | ||
Colloidal chemical synthesis and characterization of InAs nanocrystal quantum dots | Q56921664 | ||
P433 | issue | 27 | |
P921 | main subject | chemotherapy | Q974135 |
nanocarrier | Q17153796 | ||
P304 | page(s) | 4776-4806 | |
P577 | publication date | 2014-07-01 | |
P1433 | published in | Organic and Biomolecular Chemistry | Q3355939 |
P1476 | title | Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy | |
P478 | volume | 12 |
Q34507785 | "Turn-on" fluorescence probe integrated polymer nanoparticles for sensing biological thiol molecules |
Q38904231 | An iGlu receptor antagonist and its simultaneous use with an anticancer drug for cancer therapy |
Q92355546 | Analysis of phototoxin taste closely correlates nucleophilicity to type 1 phototoxicity |
Q48109107 | Anions as Triggers in Controlled Release Protocols from Mesoporous Silica Nanoparticles Functionalized with Macrocyclic Copper(II) Complexes. |
Q35684637 | Clean Photothermal Heating and Controlled Release from Near-Infrared Dye Doped Nanoparticles without Oxygen Photosensitization |
Q57365274 | Dendritic nanocarriers based on hyperbranched polymers |
Q92271629 | Efficacious Doxorubicin Delivery Using Glutathione-Responsive Hollow Non-phospholipid Vesicles Bearing Lipoyl Cholesterols |
Q26801293 | Emerging therapeutic delivery capabilities and challenges utilizing enzyme/protein packaged bacterial vesicles |
Q47623795 | Hydrazine functionalized probes for chromogenic and fluorescent ratiometric sensing of pH and F-: experimental and DFT studies. |
Q41654060 | Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery |
Q52991579 | Light-responsive peptide [2]rotaxanes as gatekeepers of mechanised nanocontainers. |
Q47811202 | Nanoprodrug of retinoic acid-modified paclitaxel |
Q39012279 | Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes. |
Q92223345 | Near Infrared Boron Dipyrromethene Nanoparticles for Optotheranostics |
Q38555019 | Polymeric 3D nano-architectures for transport and delivery of therapeutically relevant biomacromolecules. |
Q38691862 | Recent advances in multifunctional silica-based hybrid nanocarriers for bioimaging and cancer therapy. |
Q50539703 | Redox and pH Dual Responsive Polymer Based Nanoparticles for In Vivo Drug Delivery |
Q46427464 | Responsive mesoporous silica nanoparticles for sensing of hydrogen peroxide and simultaneous treatment toward heart failure. |
Q38269215 | Silica-based nanoparticles: a versatile tool for the development of efficient imaging agents. |
Q61800969 | Spatially Controlled Surface Modification of Porous Silicon for Sustained Drug Delivery Applications |
Q50764923 | Tailoring luminescence color conversion via affinitive co-assembly of glutamates appended with pyrene and naphthalene dicarboximide units |
Search more.